Patents Assigned to Glyscend, Inc.
  • Patent number: 11576928
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: February 14, 2023
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • Patent number: 11491182
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: November 8, 2022
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • Patent number: 11491183
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: November 8, 2022
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik
  • Patent number: 11484548
    Abstract: The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: November 1, 2022
    Assignee: Glyscend, Inc.
    Inventors: Thomas Henry Jozefiak, Ashish Nimgaonkar, Steven C. Polomoscanik